| 267 |
Next-Generation PCI Guidance System: A Closer Look at AVVIGO+ |
Sang Yong Jo |
Apr. 17. 25 |
| 266 |
FATE-MAIN Trial: FFR- vs. Angiography-Guided Left Main PCI |
Seongbong Wee |
Apr. 17. 25 |
| 265 |
Indirect Assessment of Microvascular Function by Pressure Wire and Its Prognostic Value- Coronary Pressure Reserve |
Jung-Min Ahn |
Apr. 17. 25 |
| 264 |
Development and Validation of Modified Residual Functional SYNTAX Score |
Kefei Dou |
Apr. 17. 25 |
| 263 |
Influence of Revascularization Decisions by Computational Physiology and Plaque Vulnerability |
Shengxian Tu |
Apr. 17. 25 |
| 262 |
Decoding the FLAVOUR Trials: Transforming the Paradigm of PCI With Physiology and Imaging |
Jian'an Wang |
Apr. 17. 25 |
| 261 |
Long-Term Final 5-Year Results of FAME-3 Trial |
William F. Fearon |
Apr. 17. 25 |
| 260 |
Key Findings of the FLAVOUR II Trial |
Jian'an Wang |
Apr. 17. 25 |
| 259 |
Coronary Computational Physiology: Current and Future Perspective |
Shengxian Tu |
Apr. 16. 25 |
| 258 |
Pressure Pullback Gradient(PPG) to Personalize PCI: The PPG Global Registry |
Carlos Collet |
Apr. 16. 25 |
